Vertex Pharmaceuticals, Inc. Community Page | What other sites are saying about Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

(NQ: VRTX)

78.43 USD -1.04 (-1.31%)

Official Closing Price / Updated: 4:00 PM EDT, May 22, 2013 / Add to My Watchlist

(VRTX) Community Analysis from

Related Wikinvest articles

May 22, 2013

(VRTX) Actelion Beats Earnings – Sales Rise

(Stock Blog Hub, 4/27/13)

Actelion Ltd. (ALIOF) reported first quarter 2013 earnings of $1.35 per American Depository Receipt (ADR), up 56.1% from the prior-year earnings of 87 cents per ADR. Earnings were well...(read more)

(VRTX) Vertex Pharmaceuticals Posts Disappointing Quarter

(Stock Blog Hub, 11/24/12)

Vertex Pharmaceuticals Inc. (VRTX) posted break-even (including stock-based compensation expense) results in the third quarter of 2012, well below the year-ago earnings...(read more)

Buffett Was a Buyer on Friday (TSN, PETS, BSFT, VRTX)

(tickerspy.com, 5/7/12)

Stocks ended the day mixed following Friday's big sell-off. The market looked poised to continue the downward trend following the results of the French election, but stocks quickly regained their composure to trade pretty much...(read more)

View all posts about Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals (VRTX) Company Overview

There is no analysis for VRTX yet. But you can go to Wikinvest to help create one!